William Catalona
William Catalona
Professor of urology, northwestern university
Verified email at nm.org - Homepage
TitleCited byYear
Measurement of prostate-specific antigen in serum as a screening test for prostate cancer
WJ Catalona, DS Smith, TL Ratliff, KM Dodds, DE Coplen, JJJ Yuan, ...
New England Journal of Medicine 324 (17), 1156-1161, 1991
Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men
WJ Catalona, JP Richie, FR Ahmann, MLA Hudson, PT Scardino, ...
The Journal of urology 151 (5), 1283-1290, 1994
Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial
WJ Catalona, AW Partin, KM Slawin, MK Brawer, RC Flanigan, A Patel, ...
Jama 279 (19), 1542-1547, 1998
Detection of organ-confined prostate cancer is increased through prostate-specific antigen—based screening
WJ Catalona, DS Smith, TL Ratliff, JW Basler
Jama 270 (8), 948-954, 1993
High-throughput oncogene mutation profiling in human cancer
RK Thomas, AC Baker, RM DeBiasi, W Winckler, T LaFramboise, WM Lin, ...
Nature genetics 39 (3), 347-351, 2007
Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24
J Gudmundsson, P Sulem, A Manolescu, LT Amundadottir, ...
Nature genetics 39 (5), 631-637, 2007
Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination: enhancement of specificity with free PSA measurements
WJ Catalona, DS Smith, DK Ornstein
Jama 277 (18), 1452-1455, 1997
Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies
WJ Catalona, GF Carvalhal, DE Mager, DS Smith
The Journal of urology 162 (2), 433-438, 1999
Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy
AV D'Amico, MH Chen, KA Roehl, WJ Catalona
New England Journal of Medicine 351 (2), 125-135, 2004
Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening
WJ Catalona, DS Smith, RL Wolfert, TJ Wang, HG Rittenhouse, TL Ratliff, ...
Jama 274 (15), 1214-1220, 1995
Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results
KA Roehl, M Han, CG Ramos, JAV Antenor, WJ Catalona
The Journal of urology 172 (3), 910-914, 2004
A common variant associated with prostate cancer in European and African populations
LT Amundadottir, P Sulem, J Gudmundsson, A Helgason, A Baker, ...
Nature genetics 38 (6), 652-658, 2006
Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes
J Gudmundsson, P Sulem, V Steinthorsdottir, JT Bergthorsson, ...
Nature genetics 39 (8), 977-983, 2007
Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer
DL Lamm, APM Van Der Meijden, A Morales, SA Brosman, WJ Catalona, ...
The Journal of urology 147 (3 Part 1), 596-600, 1992
Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values
DW Keetch, WJ Catalona, DS Smith
The Journal of urology 151 (6), 1571-1574, 1994
5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer
WJ Catalona, DS Smith
The Journal of urology 152 (5), 1837-1842, 1994
Potency, continence and complications in 3,477 consecutive radical retropubic prostatectomies
SD Kundu, KA Roehl, SE Eggener, JAV Antenor, M Han, WJ Catalona
The Journal of urology 172 (6 Part 1), 2227-2231, 2004
Sequence variants at the TERT-CLPTM1L locus associate with many cancer types
T Rafnar, P Sulem, SN Stacey, F Geller, J Gudmundsson, A Sigurdsson, ...
Nature genetics 41 (2), 221, 2009
Clinical use of prostate specific antigen in patients with prostate cancer
MA Hudson, RR Bahnson, WJ Catalona
The Journal of urology 142 (4), 1011-1017, 1989
Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels
RB Nadler, PA Humphrey, DS Smith, WJ Catalona, TL Ratliff
The Journal of urology 154 (2), 407-413, 1995
The system can't perform the operation now. Try again later.
Articles 1–20